Kubota Pharmaceutical Holdings Co., Ltd. provided consolidated financial guidance for the year ending Dec. 31, 2021. For the year, the company expects, operating loss of ¥2,900 million and net loss of ¥2,800 million or ¥62.84 per basic diluted share on revenue of ¥10 million.